AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

KALA BIO, Inc. Director's Dealing 2025

Nov 26, 2025

35091_dirs_2025-11-26_6d9a4d6f-fba0-4702-b885-d8fb7bba8e79.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-11-24

Reporting Person: Lazar David E. (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Footnotes

F1: No shares of common stock are beneficially owned.